The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
2015 · Translational Psychiatry · 139 citations
https://doi.org/10.1038/tp.2015.47
A
Ari Illi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
1.5K
Citations
27
h-index
37
i10-index
Ari Illi is an academic researcher from Tampere University. The author has contributed to research in topics: Bipolar Disorder and Treatment & Treatment of Major Depression & Neurotransmitter Receptor Influence on Behavior. The author has an h-index of 27, co-authored 38 publications.
Papers by this author
works5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression
2009 · Neuroreport · 119 citations
https://doi.org/10.1097/wnr.0b013e32832eb708
Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression
2010 · Neuroscience Letters · 76 citations
https://doi.org/10.1016/j.neulet.2010.04.039
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression
2019 · Journal of Neural Transmission · 46 citations
https://doi.org/10.1007/s00702-018-01966-x
P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT
2011 · Neuroscience Letters · 43 citations
https://doi.org/10.1016/j.neulet.2011.02.023
TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response
2009 · Neuroscience Letters · 38 citations
https://doi.org/10.1016/j.neulet.2009.10.069
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat